Syndax Pharmaceuticals Inc (SNDX)
EBITDA Margin
-53.67%
TTM · Period ending:
SNDX EBITDA Margin
Latest reported-53.67%period ending
Latest reported-53.67%period ending
SNDX TTM EBITDA Margin (-1742.25% → -53.67%)
TTM ebitda margin
High-resolution chart · PNG
SNDX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -53.667% | |
| -74.8225% | |
| -130.2306% | |
| -267.5987% | |
| -422.3344% | |
| -764.5167% | |
| -1,325.2576% | |
| -1,855.4063% | |
| -7,538.2% | |
| -8.5419% | |
| 2.0532% | |
| 12.5257% | |
| 19.2364% | |
| -660.0533% | |
| -5,866.1833% | |
| -5,479.5649% | |
| -4,667.4357% | |
| -4,265.2604% | |
| -3,803.8233% | |
| -3,705.8668% | |
| -3,663.5465% | |
| -4,007.2512% | |
| -4,331.3777% | |
| -4,592.4192% | |
| -4,959.3935% | |
| -3,261.073% | |
| -3,261.4805% | |
| -3,138.0385% | |
| -2,938.9943% | |
| -4,368.5246% | |
| -4,364.0984% | |
| -3,942.8689% | |
| -3,576.3934% | |
| -3,218.6066% | |
| -2,434.1803% | |
| -2,799.5708% | |
| -3,465.7097% | |
| -5,688.1988% | |
| -1,674.6097% | |
| -1,806.3333% | |
| -1,776.4167% | |
| -1,742.25% |